Hi
I'm afraid the authors of ISO 22870 would disagree as the scope (paragraph 1) of this standard (and 15189) says that as a quality management system, it can be applied to transcutaneous methods. This is particularly pertinent in light of the introduction of the Masimo Hb sensor. I would rather know that these exist in my organisation and have an idea of what is happening with them, than them just appearing through Medical engineering.
Thanks,
David Ryder, Point of Care Testing Coordinator
University Hospitals of Morecambe Bay NHS Foundation Trust
Furness General Hospital
Dalton Lane
Barrow-in-Furness, Cumbria, LA14 4LF
External: 01229 491171 | Extension: 51171 | Mobile: 07580 818900
-----Original Message-----
From: ACB Point-of-Care Testing [mailto:[log in to unmask]] On Behalf Of Brown Stephen (THE PATHOLOGY PARTNERSHIP)
Sent: 20 June 2016 10:12
To: [log in to unmask]
Subject: Re: ACB-POCT Digest - 7 Jun 2016 to 8 Jun 2016 (#2016-78)
This is an interesting study and would welcome sight of the results for future reference.
However when we have reviewed this sort of equipment, for POCT support, we decided as this did not involve a sample then this did not constitute a POCT test in the true sense of the word.
What are other users view on the status of this piece of equipment, POCT or not?
Stephen
Stephen Brown CSci FIBMS
POCT Manager, The Pathology Partnership
Iconix One | Iconix Park | London Road | Pampisford |CAMBRIDGE CB22 3EG
M: 07487 777259
L : 01223 632933
E : [log in to unmask]
The Pathology Partnership is an NHS pathology provider | http://thepathologypartnership.info/
Date: Wed, 8 Jun 2016 19:24:52 +0100
From: Joanne Morris <[log in to unmask]>
Subject: Draeger transcutaneous bilirubinometer evaluation/audit
We are planning a clinical audit of the use of the Draeger transcutaneous bilirubinometers used by our community midwife team. The aim of the audit is to assess the clinical effectiveness of the meters in screening babies who require referral and treatment and to compare the values from the meter to the results produced when they babies arrive at the hospital for further assessment.
I was wondering if anyone else has audited the use of this instrument and would be willing to share the structure and content of the audit? I would also be interested in any evaluation data comparing the meters to lab methods or other available POCT methods for bilirubin?
Best wishes
Joanne Morris
Consultant Clinical Scientist
Whittington Health
------------------------------
End of ACB-POCT Digest - 7 Jun 2016 to 8 Jun 2016 (#2016-78)
************************************************************
********************************************************************************************************************
This message may contain confidential information. If you are not the intended recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be accessed anywhere
For more information and to find out how you can switch, visit www.connectingforhealth.nhs.uk/nhsmail
********************************************************************************************************************
|